Answers are grounded in this paper and cite their sources.
In this issue of The Journal of Physiology, Stevens et al. (2017) studied the protective effect of overexpression of the vascular endothelial growth factor (VEGF)-A165b splice isoform in the kidney, leading to rescue of abnormal glomerular permeability and proteinuria, which was present in knock-out mice of all VEGF-A isoforms. This well-performed study proposes that a mouse model with progressive depletion of all VEGF-A isoforms results in proteinuria and increased glomerular water permeability. In contrast, overexpression of the VEGF-A165 isoform protects against those abnormalities. VEGF has been shown to have both useful actions and deleterious effects in physiological and pathological processes. In pathology, mainly in diabetic retinopathy, treatment has been focused on blocking the participation of VGEF in the development of microaneurisms in retina to prevent loss of vision. On the peritoneum it has been claimed that VGEF induces proliferation of vessels in the submesothelial area. This vascular proliferation would lead to a decrease in the efficacy of the peritoneum for dialytic procedures, since the presence of more vessels would facilitate the dissipation of the osmotic gradient between the abdominal cavity containing hyperosmotic dialysis solutions and the submesothelium with a lower osmotic content. This is also classified as a deleterious action of VGEF. In contrast to those two effects, Stevens et al. point out the beneficial effect of the VEGF-A165b isoform in protecting against proteinuria. This is a most relevant issue, since it has been claimed that proteinuria by itself may participate in the deterioration of renal function in the long term. Proteinuria may be a consequence of abnormal permeability of glomerular capillaries and/or of impaired absorption of proteins in the proximal tubules, associated with the protein megalin and with other transporters of macromolecules. Peired et al. (2013) reported that proteinuria impairs glomerular podocyte regeneration by sequestering retinoic acid. Molina-Jijon et al. (2015) reported that retinoic acid reverses proteinuria in a model of diabetic nephropathy, even in the presence of persistent hyperglycaemia. In this model, damage of claudin-5 in glomerular capillaries was observed, which was also ameliorated by retinoic acid. The study by Steven et al. is an interesting example of research in an animal model using molecular approaches, leading to results that might in turn lead to translational physiological research with applications in clinical practice. For instance, PECAM was studied to disclose possible cellular signals involved in the regulation of glomerular capillary function by the VEGF-A165b isoform. Partial restoration of capillary circumference and of glomerular capillary density was achieved, suggesting the role of additional cellular signalling pathways in the vascular response to VEGF-A165. In agreement with this suggestion, Stevens et al. found that expression of the receptor VEGFR-2 was increased in glomeruli. An interesting finding is that overexpression of the VEGF-A165b splice isoform resulted in a protective effect on renal function. This effect was associated with restoration of the glomerular capillary circumference and of the capillary density, which were reduced in the VEGF-A-KO animals, and suggests a central role of this isoform in glomerular physiology and pathophysiology. Those findings emphasize the potential use of the VEGF-A165b splice isoform in medicine and the need for basic research to support this. None declared.
No takes yet. Share an insight, caveat, or question.
José L. Reyes (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: